Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China
· Delayed Price · Currency is CNY 37.89
-0.99 (-2.55%)
At close: Apr 29, 2026
SHE:301281 Revenue
Shandong Keyuan Pharmaceutical had revenue of 161.30M CNY in the quarter ending March 31, 2026, with 45.05% growth. This brings the company's revenue in the last twelve months to 448.33M, up 4.59% year-over-year. In the year 2025, Shandong Keyuan Pharmaceutical had annual revenue of 398.23M, down -14.12%.
Revenue (ttm)
448.33M
Revenue Growth
+4.59%
P/S Ratio
9.39
Revenue / Employee
644.15K
Employees
696
Market Cap
4.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 398.23M | -65.49M | -14.12% |
| Dec 31, 2024 | 463.72M | 16.13M | 3.60% |
| Dec 31, 2023 | 447.58M | 4.72M | 1.07% |
| Jan 1, 2023 | 442.87M | 21.98M | 5.22% |
| Jan 1, 2022 | 420.89M | 53.83M | 14.67% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Haisen Pharmaceutical | 532.26M |
| Guangdong Jiaying Pharmaceutical | 410.00M |
| Hangzhou Minsheng Healthcare | 827.65M |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| Zhejiang Zhenyuan Share | 2.67B |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Zhejiang Int'l Group | 33.68B |
| Hubei Guangji Pharmaceutical | 638.58M |